drugset
drugset / Trial / NCT03593954

A Study to Assess the Effect of Ritonavir on the Single-Dose Pharmacokinetics of JNJ-61393215 in Healthy Participants

NCT03593954 ↗

Phase 1 Completed 12 enrolled Janssen Research & Development, LLC
NaSingle-groupOpen-labelOther

Summary

The primary purpose of this study is to assess the effect of ritonavir, on the single-dose pharmacokinetics (PK) of JNJ-61393215 in healthy participants.

Timeline

Start
2018-07-31
Primary completion
2018-09-19
Completion
2018-09-19

Drugs

EvaluationDrugModalityDoseRoute
Subject Ritonavir Other / unclassified 100 mg Oral
Subject TEBITOREXANT Small molecule 2 mg Oral

Indications

No indication recorded.